Klow Blend by Dragon Pharma

Dragon Pharma Original Formula

BPC-157 + TB-500 + KPV + GHK-Cu

Klow Blend80 mg vial
Class 4-Peptide Recovery Blend
Total Content 80 mg
Action Local + Systemic + Immune
Suppression None (HPG)
Reconstitution Bacteriostatic Water
Form Subcutaneous Vial
Availability: In Stock
$200.00
Quantity
Shipping
Wishlist

Klow Blend 80mg — BPC-157, TB-500, KPV and GHK-Cu by Dragon Pharma

Klow Blend is Dragon Pharma's advanced 4-peptide formulation combining BPC-157, TB-500, KPV and GHK-Cu in a single 80mg vial. Each component works through a distinct mechanism — localised tissue repair, systemic recovery, immune modulation and collagen-driven skin regeneration — covering a broader spectrum of recovery and repair than any single peptide or two-component blend can achieve.

Also searched as: Klow Blend 80mg, BPC-157 TB-500 KPV GHK-Cu blend, 4-peptide recovery blend, Klow Blend Dragon Pharma.

The Four Components — Mechanisms and Roles

Understanding why these four peptides are combined requires understanding what each one does and — critically — what the others cannot:

Peptide Mechanism Primary Role in Blend Unique Contribution
BPC-157 Upregulates growth hormone receptors; promotes angiogenesis and VEGF activity Localised tendon, ligament and gut repair Most effective near the injury site; the only component with documented gut-protective properties
TB-500 Thymosin Beta-4 fragment; promotes actin polymerisation and cell migration to damaged tissue Systemic tissue repair and anti-inflammation Works systemically regardless of injection site; reaches injuries BPC-157 cannot when site injection isn't practical
KPV Alpha-MSH-derived tripeptide; binds MC1R and MC3R receptors; reduces NF-κB pathway activation Anti-inflammatory and immune modulation The only component specifically targeting immune-driven inflammation; addresses gut and skin inflammation through a different pathway than BPC-157
GHK-Cu Copper tripeptide; upregulates collagen, elastin and glycosaminoglycan synthesis; activates TGF-β Skin regeneration and collagen repair The only component with documented effects on skin quality and hair growth; functions at concentrations as low as 1 nanomolar

Why These Four Together — The Information Gap

Most peptide blends combine compounds from the same functional category — BPC-157 + TB-500 is a local + systemic pairing within the same tissue repair category. Klow Blend extends beyond this by adding two compounds from entirely different functional categories:

  • BPC-157 + TB-500 — cover tissue repair from complementary angles (localised vs systemic)
  • KPV — addresses the immune-inflammatory component of recovery, which tissue repair peptides alone do not. Chronic low-grade inflammation is increasingly recognised as a limiting factor in tissue healing — particularly relevant in AAS users where systemic inflammatory markers can be elevated
  • GHK-Cu — activates collagen and extracellular matrix remodelling at the protein synthesis level, which is distinct from the wound-healing and cell migration mechanisms of BPC-157 and TB-500

The result is a blend covering four distinct biological pathways simultaneously: localised growth factor signalling (BPC-157), systemic cell migration (TB-500), NF-κB immune pathway modulation (KPV), and TGF-β collagen remodelling (GHK-Cu).

KPV — The Least Known Component

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). Unlike BPC-157 or TB-500 which are widely discussed in bodybuilding contexts, KPV remains less well-known despite a meaningful body of research:

  • KPV binds melanocortin receptors MC1R and MC3R — receptors involved in systemic anti-inflammatory signalling
  • Studies have demonstrated KPV reduces intestinal inflammation through direct NF-κB pathway inhibition — a mechanism distinct from BPC-157's gut protection via gastric protein pathways
  • KPV has demonstrated wound healing activity in dermal tissue, complementing GHK-Cu's collagen synthesis role
  • Unlike most anti-inflammatory compounds, KPV achieves its effects at very low doses without the immunosuppressive risks associated with corticosteroids

GHK-Cu — Concentration and Potency

GHK-Cu (Copper Tripeptide-1) is notable for its extreme biological potency at very low concentrations — active effects have been documented at concentrations of 1 nanomolar (0.000001 mg/ml), making it one of the most potent naturally occurring peptides by molar concentration. Its primary roles in the blend:

  • Stimulates collagen and glycosaminoglycan synthesis in fibroblasts — rebuilding extracellular matrix damaged by training or injury
  • Activates antioxidant defence via superoxide dismutase upregulation
  • Promotes skin barrier repair and wound healing complementary to KPV's anti-inflammatory action

Effects and Benefits

  • Localised tissue repair from BPC-157 near injury sites
  • Systemic recovery support throughout the body from TB-500
  • Immune-inflammatory modulation via KPV's NF-κB pathway action
  • Collagen and extracellular matrix remodelling from GHK-Cu
  • Skin quality and regeneration support
  • No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

Protocol Typical Dose Frequency
General recovery and skin support 500 mcg – 1 mg Daily or every other day
Acute injury or inflammation 1–2 mg Daily for 2–4 weeks

Because the blend contains both localised (BPC-157) and systemic (TB-500, KPV, GHK-Cu) components, injection site location has a moderate effect — injecting near a specific injury or area of concern takes advantage of BPC-157's localised mechanism, while the remaining three components work systemically regardless. Reconstitute with bacteriostatic water and dose based on total blend volume.

Klow Blend vs Other Dragon Pharma Recovery Peptides

Reconstitution and Storage

Klow Blend is supplied as a lyophilised powder requiring reconstitution with bacteriostatic water. Add bacteriostatic water slowly along the vial wall and swirl gently — do not shake. Store reconstituted vial refrigerated at 2-8°C, stable for approximately 28-30 days. Never freeze a reconstituted peptide vial.

"Klow Blend was developed to address the full recovery spectrum — not just tissue repair but the immune-inflammatory and collagen remodelling components that single-compound or two-component blends leave unaddressed. It is the most advanced recovery formulation in our peptide range."

Stacking and Related Compounds

Klow Blend is often combined with:

  • Dragontropin (HGH) for users adding direct GH elevation to a comprehensive recovery protocol
  • Ipamorelin for GH secretagogue support alongside peptide recovery
  • Glow Blend for users combining recovery with skin and beauty-focused peptide protocols
Please log in to write review.

KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-melanocyte-stimulating hormone that binds melanocortin receptors MC1R and MC3R, reducing inflammation through NF-κB pathway inhibition — a mechanism entirely distinct from BPC-157 and TB-500's tissue repair actions. It specifically addresses the immune-inflammatory component of recovery that tissue repair peptides alone do not target.

Klow Blend adds two additional components operating through different biological pathways. KPV modulates immune-driven inflammation via NF-κB inhibition. GHK-Cu drives collagen and extracellular matrix remodelling via TGF-β activation and fibroblast stimulation. The BPC-157 + TB-500 blend covers tissue repair only — Klow Blend covers tissue repair, systemic recovery, immune modulation and collagen remodelling simultaneously.

GHK-Cu (Copper Tripeptide-1) has documented biological activity at concentrations as low as 1 nanomolar — among the lowest effective concentrations of any naturally occurring peptide. This high potency means meaningful effects on collagen synthesis, antioxidant defence and wound healing are achievable even within a multi-component blend where each peptide shares the total vial content.

Moderately. BPC-157 in the blend is most effective when administered near the specific area requiring repair — this is an inherent property of its localised mechanism. TB-500, KPV and GHK-Cu all work systemically regardless of injection site, so the blend as a whole remains effective from any injection location, with the localised benefit of BPC-157 being the variable element.

BPC-157's origin as a gastric-protective compound means it has documented gut tissue support properties, and KPV has separately demonstrated intestinal anti-inflammatory activity through NF-κB pathway inhibition in research settings. Both components contribute to the blend's potential relevance for digestive concerns.

No. None of the four components — BPC-157, TB-500, KPV or GHK-Cu — affects testosterone, estrogen or the HPG axis. The blend can be used during AAS cycles, during PCT, or independently at any time without requiring its own hormonal recovery protocol.